Skip to main content

Table 2 Total number of events and incidence rate with exact 95% Poisson confidence interval for the outcomes of individuals without type 2 diabetes (Non-T2D) and individuals with type 2 diabetes (T2D), respectively, undergoing carotid intervention

From: Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study

Outcome

Non-T2D (n = 4162)

T2D (n = 1341)

Events (n)

Incidence rate (per 1000 patients)

Events (n)

Incidence rate (per 1000 patients)

Stroke

453

25.1 (22.8–27.5)

193

35.7 (30.8–41.1)

Ischemic stroke

380

20.8 (18.8–23.0)

166

30.3 (25.9–35.3)

Hemorrhagic stroke

68

3.5 (2.7–4.5)

20

3.4 (2.1–5.2)

Death

725

37.4 (34.7–40.2)

324

54.5 (48.7–60.7)

Cardiovascular death

161

8.3 (7.1–9.7)

89

15.0 (12.0–18.4)

MACE

1248

82.7 (78.2–87.4)

551

135 (123.4–146.1)

  1. HR hazard ratio, MACE major adverse cardiovascular events, i.e. non-fatal myocardial infarction, non-fatal stroke and cardiovascular death